Does BEVACIZUMAB Cause Immune-mediated hepatitis? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Immune-mediated hepatitis have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.1% of all adverse event reports for BEVACIZUMAB.
108
Reports of Immune-mediated hepatitis with BEVACIZUMAB
0.1%
of all BEVACIZUMAB reports
27
Deaths
44
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From BEVACIZUMAB?
Of the 108 reports, 27 (25.0%) resulted in death, 44 (40.7%) required hospitalization, and 13 (12.0%) were considered life-threatening.
Is Immune-mediated hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
CARBOPLATIN (213)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
TREMELIMUMAB (51)
Which BEVACIZUMAB Alternatives Have Lower Immune-mediated hepatitis Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ